← Eichor
Study identifier: NCT06018831 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Urine and Ultrasound Screening for Kidney Disease in Children

Condition: Kidney Diseases · Diagnostic Techniques · Ultrasound  ·  Sponsor: Children's Hospital of Fudan University

PhaseNA
Planned participants13000
Who can joinAll sexes, N/A to 6 Years
Healthy volunteersYes

About this study

The aim of this study is to early detect kidney disease in the natural population cohort of children by urine and ultrasound screening, to assist in the precise prevention and treatment of children's kidney disease, and to establish a risk prediction system for children's kidney disease. About 10,000 children called KunQi Cohort are born in Jiangsu Province(8,000 in Kunshan and 2,000 in Qidong) and about 3,000 born in Shanghai. Through the project, child who is found with abnormal urine or ultrasound result will be referred to Children's Hospital of Fudan University to get further examination and treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Yihui Zhai  ·  +8613916488230  ·  marinezyh@163.com

Hong Xu, PhD.MD.  ·  +8602164932829  ·  hxu@shmu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (2)

Qidong City Maternal and Child Health HospitalNantong, Jiangsu, ChinaRecruiting
Kunshan City Maternal and Child Health HospitaSuzhou, Jiangsu, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06018831